Clinical outcomes of rotational atherectomy in severely calcified in-stent restenosis: a single-center, retrospective study

Nagoya J Med Sci. 2019 May;81(2):313-323. doi: 10.18999/nagjms.81.2.313.

Abstract

Neointimal calcification after stent implantation has been reported as one of the forms of neoatherosclerosis. There are a few patients with in-stent restenosis (ISR) and an undilatable calcified neointima who require rotational atherectomy to achieve sufficient acute gain in lumen diameter. However, the clinical outcomes of rotational atherectomy for undilatable calcified ISR have not been fully elucidated. Therefore, we investigated the safety and efficacy of rotational atherectomy for treating calcified ISR. This retrospective study included 17 patients (20 lesions) who had undergone percutaneous coronary intervention including rotational atherectomy to treat ISR with severely calcified neointima. Kaplan-Meier analysis was used to analyze the data. The mean age of the enrolled patients was 67±18 years, and 71% were men. The patients had highly atherogenic characteristics: 65% had diabetes mellitus and 53% were receiving hemodialysis. Procedural success was obtained in 19 (95%) patients, and the acute gain in lumen diameter was acceptable (1.7±0.6 mm). However, during a median follow-up of 571 days, the incidences of major adverse cardiac and cerebrovascular events per patient and clinical-driven target lesion revascularizations per lesion were relatively high. There were no differences in clinical outcomes according to the baseline characteristics, type of restenotic stents, and therapeutic strategy. In conclusion, clinical outcomes of rotational atherectomy for severely calcified ISR were unfavorable despite a high success rate and acceptable acute gain in lumen diameter.

Keywords: calcified neointima; in-stent restenosis; rotational atherectomy, and major adverse cardiac and cerebrovascular events.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Atherectomy / methods*
  • Coronary Restenosis / surgery*
  • Drug-Eluting Stents / adverse effects*
  • Humans
  • Kaplan-Meier Estimate
  • Middle Aged
  • Neointima / surgery
  • Retrospective Studies